Next Article in Journal
Two-Month Consumption of Orange Juice Enriched with Vitamin D3 and Probiotics Decreases Body Weight, Insulin Resistance, Blood Lipids, and Arterial Blood Pressure in High-Cardiometabolic-Risk Patients on a Westernized Type Diet: Results from a Randomized Clinical Trial
Previous Article in Journal
Dietary Strategies in Postmenopausal Women with Chronic and Metabolic Diseases
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 16
Issue 9
10.3390/nu16091330
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Nano-Selenium Alleviates Cd-Induced Chronic Colitis through Intestinal Flora

by
Chengdong Zhou
1,
Shengliang Guo
1,
Pin Gong
1,
Qian Ba
2,* and
Wenbo Yao
1,3,*
1
School of Food Science and Engineering, Shaanxi University of Science and Technology, Xi’an 710021, China
2
Laboratory Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 274 Zhijiang Middle Road, Shanghai 200071, China
3
Department of Pediatrics, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 274 Zhijiang Middle Road, Shanghai 200071, China
*
Authors to whom correspondence should be addressed.
Nutrients 2024, 16(9), 1330; https://doi.org/10.3390/nu16091330
Submission received: 20 March 2024 / Revised: 21 April 2024 / Accepted: 26 April 2024 / Published: 28 April 2024
(This article belongs to the Section Prebiotics and Probiotics)
Browse Figures
Versions Notes

Abstract

:
Background: Cadmium (Cd) is an environmental contaminant that poses risks to human and animal health. Selenium (Se), a beneficial element, alleviates the detrimental consequences of colitis and Cd toxicity. Se is found in food products as both inorganic Se (sodium selenite) and organic Se (typically Se-enriched yeast). Nano-selenium (nano-Se; a novel form of Se produced through the bioreduction of Se species) has recently garnered considerable interest, although its effects against Cd-induced enterotoxicity are poorly understood. The aim of this study was to investigate the impact of nano-selenium on mitigating cadmium toxicity and safeguarding the integrity of the intestinal barrier. Methods: For a total of two cycles, we subjected 6-week-old C57 mice to chronic colitis by exposing them to Cd and nano-selenium for two weeks, followed by DSS water for one week. Results: The application of nano-selenium mitigated the intensity of colitis and alleviated inflammation in the colon. Nano-selenium enhanced the diversity of the intestinal flora, elevated the concentration of short-chain fatty acids (SCFAs) in feces, and improved the integrity of the intestinal barrier. Conclusions: In summary, nano-Se may reduce intestinal inflammation by regulating the growth of intestinal microorganisms and protecting the intestinal barrier.

1. Introduction

Cadmium (Cd) contamination represents one of the most severe forms of heavy metal pollution in China. The detrimental effects of chronic dietary Cd exposure on the human body are a prominent concern in the realm of food safety. Consequently, Cd is classified as a Class I human carcinogen [1,2,3]. According to the International Agency for Research on Cancer, Cd can infiltrate the human body via the food chain and accumulate within the body after binding to metallothionein. This accumulation may result in acute or chronic toxicity to various organs and systems (including the liver, kidneys, lungs, testicles, brain, bones, nervous system, and blood), with only negligible Cd excreted via the kidneys [4,5]. Research indicates that chronic Cd exposure increases the risk of musculoskeletal disorders, peripheral neuropathy, altered equilibrium, poor performance with regard to visuomotor tasks, and malignancies in humans [6,7,8,9,10]. Therefore, abating Cd toxicity and decreasing Cd accumulation are vital for human and animal safety.
The toxic effects and long-term accumulation of Cd primarily affect the intestinal tract [11,12]. Cd ingestion over an extended duration worsens colitis and damages the intestinal barrier in rodents [13]. Elevated concentrations of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interferon-γ (IFN-γ), and IL-17 have been observed in the intestinal tract in conjunction with alterations in intestinal morphology [14].
Selenium (Se), an essential trace element and component of selenocysteine, participates in numerous biological processes; therefore, Se supplementation may have health benefits. The results of numerous studies have shown that Se has numerous functions, encompassing antioxidative properties, cancer-resistance mechanisms, immune regulation, hypoglycemia regulation, and modulation of the intestinal microbiome [15,16,17,18]. In particular, Se supplementation positively contributes to human health by enhancing the immune system and preventing or treating cancer, cardiovascular disease, HIV infection, and inflammatory bowel disease (IBD) [19,20,21,22,23,24,25].
Se can bolster antioxidant defense mechanisms and mitigate the production of reactive oxygen species that form following Cd exposure. Additionally, Se protects cells against the detrimental effects of excessive H2O2, detoxifies heavy metals, and inhibits the oxidative modification of lipids or fats [26]. The ingestion of Se during Cd poisoning can potentially prevent Cd accumulation in cells and tissues, increase the synthesis of antioxidant selenoproteins, and inhibit Cd toxicity through the nuclear factor-like 2 (Nrf2) pathway [27]. Furthermore, Se serves as an important regulator of the immune system by inducing the production of IgG and IgM antibodies, which subsequently boost the activities of T cells and macrophages [26].
Se is predominantly found in the environment in two forms: inorganic and organic selenium [28]. Nano-Se is a new form of Se. Compared with organic Se, nano-Se has lower toxicity. These SeNPs effectively safeguard intestinal epithelial cells in both animals and humans [29,30]. Due to its notable antibacterial and cancer-resistant attributes and high bioavailability, nano-Se has been extensively applied to treat inflammation and oxidation-mediated disorders, including diabetes and cancer [31,32,33]. Moreover, research has indicated that nano-Se supplementation can effectively mitigate the cardiotoxicity of Cd exposure in rodents with myocarditis that were exposed to Cd [34]. However, comparative studies of the ameliorative effects of nano-Se on Cd-induced enterotoxicity are limited.
In this study, we aimed to assess the protective effects of nano-Se against Cd toxicity and examine its potential to alleviate Cd-aggravated colitis. The aim of this study was to provide theoretical validation for the health implications of nano-Se and to present novel perspectives for developing secure and efficient Cd detoxification techniques.

2. Materials and Methods

2.1. Animal Husbandry and Colitis Induction

The Animal Ethics Committee of Xi’an Medical University has granted approval for all the animal studies conducted in this work (No. XYLS2024104). Male C57BL/6 J mice, aged six weeks, were obtained from Hunan SJA Laboratory Animal Co., Ltd. They were kept in a controlled environment with a temperature of 23 ± 3 °C, humidity of 35 ± 5%, and a 12 h dark/light cycle in a particular pathogen-free animal facility. The mice were provided with a conventional laboratory mouse meal that had been exposed to 60Co radiation. The diet structure was obtained from SJA Laboratory Animal Co., Ltd. in Changsha, China. The mice were divided into five groups at random: (1) control treatment group (ctrl group, n = 5); (2) Cd exposure group (Cd group, n = 10); (3) dextran sulfate sodium (DSS) treatment group (DSS group, n = 10); (4) Cd exposure with DSS treatment group (DSS + Cd group, n = 10); and (5) DSS, Cd, and nano-Se (DCS group) group, with dose of 0.5 mg·kg–1·2 day–1 or 1 mg·kg−1·2 day−1 [35]. The control mice were given plain drinking water, while the DSS mice were given DSS dissolved in drinking water at a concentration of 2% w/v (Sigma-Aldrich Inc., St. Louis, MO, USA). The DSS + Cd and Cd mice were given CdCl2 dissolved in drinking water at a concentration of 200 nM. The DCS group was administered DSS and CdCl2 dissolved in drinking water, as well as nano-selenium by intragastric administration. In order to cause long-term inflammation of the colon, the mice were treated with Cd and nano-selenium for 2 weeks, followed by two cycles of DSS treatment (36–50 kDa; Mp Biomedicals, Santa Ana, CA, USA). Each cycle included of one week of DSS administration, followed by two weeks of normal/Cd water recovery, and ongoing nano selenium therapy. Figure 1A displays a diagram illustrating the technique. This study aimed to assess the impact of a prolonged intake of nano-Se on the intestines, specifically comparing the effects between the control and Cd groups. Additionally, the study examined how Cd worsens chronic colitis generated by DSS. Notably, our findings also revealed the influence of DSS on Cd-induced intestinal damage. The study utilized a fecal occult blood test kit (Yeasen, Shanghai, China) to evaluate the presence of fecal occult blood. Based on Jiang et al., when colitis is more severe, gross blood can be seen by the naked eye without distinguishing features, and the fecal consistency presents as watery stool [14]. To establish a disease activity index (DAI) score (Table 1) [36], we assessed the consistency of feces and the presence of hidden blood in feces every 4 days, and we measured body weight every 2 days. After the end of the second cycle, the status of the mice was observed for a week, the mice were killed, and the organs of mice were collected and weighed.

2.2. Histological Scoring and Periodic Acid-Schiff Staining

Colon tissues were fixed in 4% paraformaldehyde and stained with hematoxylin and eosin (H&E). Histological examinations were performed blinded using the scoring system indicated in Table 2. When colon tissue damage was severe and only the epithelium was intact, the inflammation was considered to be severe, and the lesion degree was considered to be transmural [37]. Colon sections were stained using standard PAS protocols and images were taken using a light microscope (Leica, Shanghai, China). The number of positive cells was determined under the light microscope. We also recorded the number of GCs present among epithelial cells. This analysis was also conducted blinded.

2.3. Analysis of Intestinal Permeability

The mice were orally administered FITC-dextran (molecular weight: 4 kDa, Sigma-Aldrich) at a dose of 500 mg/kg body weight in order to measure intestinal permeability. After administering the substance orally, blood samples were taken 4 h later. The levels of FITC-dextran were measured using a sophisticated microplate reader capable of performing many functions [38,39].

2.4. Quantitative Real-Time PCR

Colon tissues were subjected to RNA extraction using a Solarbio Total RNA Extraction Kit (Invitrogen, Carlsbad, CA, USA). Subsequently, cDNA synthesis was performed using a Biosharp Reverse Transcription Kit (Lanjieke Technology Co., Ltd., Hefei, China). The qRT-PCR analysis was conducted using Biosharp SYBR Green qPCR Mix (Lanjieke Technology Co., Ltd.) and a two-step procedure. The primers used for this analysis are specified in Table 3. The relative mRNA-expression levels were calculated using the 2−ΔΔCt technique.

2.5. Serum ELISA

The blood from the orbit was obtained and subjected to centrifugation at a speed of 3000 rpm for a duration of 10 min following a clotting period of 4 h at a temperature of 4 °C. The serum was isolated and preserved for later examination of the levels of inflammatory cytokines.

2.6. Short-Chain Fatty Acid (SCFA) Analysis

Using a gas chromatography system called 2010 Plus, fitted with a DB-FFAP column (30 m × 0.25 mm, 5 μm), SCFAs were evaluated by following a method that had been published before, with some small changes [40]. The temperature of the gasification chamber, detector, intake, and column were all 240 °C. Before injection, each sample (1 μL) underwent eight solvent washes, followed by an additional 10 washes following injection. This process was performed three times for each sample. The SCFA concentrations were determined using conventional calibration curves.

2.7. Gut Microbiota Analysis

Fecal samples were dispatched to Personal Biotechnology Co., Ltd. (Shanghai, China) for the purpose of 16S rDNA gene sequencing. The XX platform (Illumina, San Diego, CA, USA) was used to undertake paired-end sequencing of DNA fragments from the microbial population. The microbiome was analyzed using Paiseno Genes Cloud Platform (www.genescloud.cn) for bioinformatics analysis. The sequencing primers utilized were as follows: the forward primer sequence was 5′-ACTCCTACGGGAGGCAGCA-3′ while the reverse primer sequence was 5′-ACTACTACHVGGGTWTCTAAT-3′. We performed sequencing specifically targeting the 16S_V3V4 region, using the gg_13 database and employing the DADA2 method as the main approach. The credibility of the experimental data was evaluated by employing rarefaction and species–accumulation curves.

2.8. Statistical Analysis

The data were analyzed using GraphPad Prism version 7 (GraphPad Software, Inc., La Jolla, CA, USA) and were reported as the mean ± SEM. The statistical significance of the differences was assessed using a one-way or two-way analysis of variance (ANOVA) for multiple groups and the Student’s t-test for two groups. A significance level of p < 0.05 was used.

3. Results

3.1. Nano-Se Relieves the Chronic Colitis Induced by DSS in Mice

Colitis was confirmed in the mice in the DSS and DSS + Cd groups based on weight loss and DAI score (Figure 1C,D). The DCS group exhibited significantly reduced colonic inflammation compared to the DSS and DSS + Cd groups, indicating that nano-Se supplementation effectively alleviated chronic colitis induced by combined treatment with DSS and Cd. Additionally, the DSS + Cd group showed significantly shorter colon lengths compared to the DCS group, as shown in Figure 1B.

3.2. Nano-Se Alleviates Colonic Inflammatory Cytokines Expression

We assessed the levels of IL-1β, IL-6, TNF-α, monocyte chemotactic protein-1 (MCP1), and IFN-γ in the colon to measure the inflammatory reaction following nano-Se therapy. Consistent with expectations, DSS stimulated the mRNA expression of IL-1β, IL-6, IL-17, TNF-α, and IFN-γ, as shown in Figure 2. In addition, when compared to the treatment of DSS + Cd, nano-Se had a considerable inhibitory effect on the expression of inflammatory cytokines in the colon, as shown in Figure 2.

3.3. Nano-Se Protects the Intestinal Barrier

Histological analysis of the colon revealed typical signs of inflammation following DSS treatment, as characterized by massive inflammatory cell infiltration and crypt damage (Figure 3). The DCS group showed significantly lower microscopic histological scores than the DSS + Cd group. Notably, only the DSS + Cd group showed more serious crypt damage in the colon. H&E staining revealed crypt damage in the DSS + Cd group. PAS staining showed that the number of GCs was markedly lower in the DSS + Cd group than in the other groups (Figure 4). In addition, the detection of intestinal leakage with FITC showed that the serum FITC contents in the control and FITC groups were significantly lower than those in the DSS and DSS + Cd groups (Figure 5).

3.4. Nano-Selenium Relieves Colitis-Related Extraintestinal Inflammation

In order to assess the impact of nano-Se on extraintestinal inflammation, we quantified the levels of inflammatory cytokines in the serum following various treatments. The levels of proinflammatory cytokines, including as IL-1β, IL-6, MCP1, TNF-α, and IFN-γ, were considerably increased when DSS and Cd were administered together. However, treatment with nano-Se resulted in a decrease in the levels of these cytokines (Figure 6). The results indicate that the use of nano-Se reduced inflammation outside the intestines.

3.5. Effect of Nano-Selenium on SCFA Production

SCFAs are produced by the gut microbiota, and increasing SCFA contents promotes good health and protects colon tissue from DSS-induced damage [41]. To further explore the effect of nano-Se on the intestinal barrier, we measured the SCFA contents in mouse feces. The fecal concentrations of caproic acid, butyric acid, and octanoic acid in the DCS group were significantly higher than those in the DSS + Cd group (Figure 7).

3.6. Nano-Se Improves DSS-Induced Changes in the Structure of Gut Microbiota

The rarefaction and species–accumulation curves of the fecal samples exhibited a predilection for an initial increase in species diversity, followed by a subsequent plateau. The experiment yielded 47,749 nucleotides with an average read length of 0.02947, indicating that the acquired data are reliable (Figure S1A–C). The findings from the ASV Venn plot and alpha-diversity analysis indicate that the species diversity and community richness of the gut microbiota were significantly lower in the mice with colitis in the DSS + Cd group than in the other groups (Figure 8A,B and Figure S2). Conversely, administering nano-Se via gastric irrigation to mice that were fed a high-fat diet resulted in a substantial increase in both the diversity and community richness of the gut microbiota (Figure S2). Principal component analysis (PCA) and non-metric multidimensional scaling (NMDS) using the Bray–Curtis distance algorithm indicate that the mice in the DCS group were considerably separated from those in the control, DSS, and DSS + CD groups. Specifically, PC1 and PC2 accounted for 85.5% of the overall variation and 72.6% and 12.9% of the variation, respectively (Figure S3A,B). Furthermore, we examined distinctions among the groups using the analysis of similarities method and Bray–Curtis distance algorithm, finding that the DCS group was not significantly different from the control, DSS, and DSS + CD groups (Figure S3C,D). These findings are consistent with the results of our NMDS analysis. Hence, the mice groupings utilized in this experiment were deemed to be ideal, and the microbiota investigations were conducted based on these classifications. The colitis mice that were exposed to nano-selenium were accurately categorized, and a microbiota study was conducted based on these categorizations.
Our analyses included taxonomic composition, species composition heatmap, hierarchical clustering, and phylogenetic analysis. The analyses of Krona species composition indicated variation at the phylum level (Figure 9 and Figure S4A–D). Firmicutes and Bacteroides are closely associated with enteritis. Che-SeNP treatment significantly increased the relative abundances of Bacteroides and decreased the relative abundance of Firmicutes. At the genus level (Figure 10A–D and Figure 11), the relative abundances of Bacteroides and Lactobacillus in the DCS group were lower than those in the DSS + Cd group, whereas the relative abundances of Allobaculum, Akkermansia, and Oscillospira in the DCS group were higher than those in the DSS + Cd group.

3.7. Conducting a Correlation Analysis to Examine the Relationship between Specific Species and Indications of Colitis

The correlations between the relative abundances of the different species and the markers of colitis were studied at the gene level (Figure 12A–C). The results showed that changes in the abundances of Bacteroides and Lactobacillus correlated positively with the expression of proinflammatory factors. Changes in Allobaculum, Akkermansia, and Oscillospira abundances correlated negatively with the expression of proinflammatory factors (Figure 12B). By downregulating the relative abundance of Bacteroides and Lactobacillus and upregulating the relative abundance of Allobaculum, Akkermansia, and Oscillospira, the expression levels of pro-inflammatory factors in mice with colitis were significantly inhibited, thereby improving the intestinal inflammation caused by long-term DSS treatment.

4. Discussion

Cd, an acknowledged environmental contaminant, can be assimilated by plants in the soil before entering the food chain, thereby posing a threat to human health [42]. Cd is associated with colitis severity, and Se supplementation can alleviate colitis by reducing the cellular and systemic harm caused by Cd [14,34]. Additionally, previous research indicated that nano-Se can mitigate the Cd-induced dysregulation of inflammatory genes [43]. However, the role of nano-selenium in antagonizing cadmium-aggravated intestinal injury is unclear. Thus, the objectives of this study were to determine whether nano-Se can alleviate Cd-aggravated colitis and to elucidate the mechanism whereby Se relieves colitis.
Chronic Cd exposure induced intestinal injury and inflammation in a previous murine model of colitis [14]. The ability of Se to counteract the deleterious effects of Cd was supported by prior data [44]. Supplemental Se prevents Cd-induced oxidative stress in the liver, reduces Cd-induced renal toxicity and DAI scores, increases colon length, and alleviates colitis symptoms in rodents [45]. In this study, nano-Se supplementation resulted in significantly lower DAI scores and weight loss than found in the DSS + Cd group, suggesting that the incidence of colitis was stably reduced.
Colitis frequently induces numerous pro-inflammatory factors and disrupts intestinal tissue integrity [46]. Thus, we evaluated the gene-expression levels of IL-6, IL-1β, TNF-α, IFN-γ, and MCP1, finding that their expression levels increased in response to Cd exposure but were substantially downregulated by nano-Se intervention. Serum analysis confirmed that Cd induced inflammation and that nano-Se supplementation alleviated this inflammation. Our results indicate that nano-Se effectively mitigated Cd-induced intestinal and systemic inflammation.
In addition to studying inflammation, we investigated the effects of Cd on the intestinal barrier. An intact intestinal mucosa prevents the infiltration of exogenous toxins and dietary contaminants into the portal venous circulation by acting as a barrier [47]. The intestinal barrier is maintained at the cellular level through tight junctions, complexes of transmembrane proteins (e.g., occludin and claudin), and scaffold proteins (e.g., ZO-1) [48]. Additionally, the adhesion-related proteins E-cadherin and β-catenin are crucial for maintaining the intestinal barrier [49]. An extended exposure to Cd in potable water decreased the number of GCs, disrupted the structural integrity of the intestines, and inhibited the expression and subcellular localization of adhesion-related and tight junction proteins. These effects were reversed in mice supplemented with nano-Se, suggesting that intestinal barrier function (facilitating the passage of substances) was compromised by long-term Cd exposure but protected by nano-Se supplementation. In this study, oral Cd administration increased serum FITC concentrations, whereas Se supplementation decreased serum FITC levels. Inflammation was induced by intestinal barrier disruption, which facilitated the entry of exogenous inflammatory mediators such as DSS. Our hypothesis posits that while maintaining the integrity of the intestinal barrier, nano-Se might mitigate inflammation in the intestines and throughout the body.
Cd exposure can disrupt the dynamic equilibrium of the gastrointestinal microbiota in mice, resulting in an increased prevalence of Bacteroidetes relative to Firmicutes and a suppressed growth of probiotics, including that of Bifidobacteria and Lactobacillus [50,51]. Substantial evidence suggests that the microbiome contributes to host diseases and is strongly correlated with the onset of IBD (35). Therefore, one potential mechanism whereby nano-Se ameliorates Cd-aggravated colitis involves the gut microbiota, so we examined the effects of nano-Se on the gut microbiota in Cd-treated rodents. Using nano-Se to treat colitis in mice substantially augmented the alpha diversity within the gut microbiota, as determined by calculations based on the Chao index, in contrast to our findings with the DSS + Cd group. The phylum-level microbial analysis revealed that rodents subjected to nano-Se treatment exhibited a notable increase in Firmicutes and a decrease in the relative abundance of Bacteroidetes compared with the corresponding abundances in the DSS group. When studying the DSS group at the genus level, we found that nano-Se significantly increased the relative abundances of Allobaculum, Akkermansia, and Oscillospira. Colitis frequently develops in response to interactions between microorganisms and SCFAs. Consequently, the intestinal microbiota is likely one of the primary targets of nano-Se during the treatment of colitis.
SCFAs are byproducts of carbohydrate metabolism by the intestinal microbiota. SCFAs are obtained from dietary fibers, including resistant starch, inulin, and polysaccharides [52]. SCFAs are predominantly absorbed by the intestinal epithelial cells in the colon and serve as essential energy sources for fundamental cellular processes [53]. SCFAs serve essential functions in maintaining intestinal homeostasis in numerous ways, including by increasing the expression of the tight junction proteins, ZO-1, and occludin in colonic intestinal cells and by substantially decreasing inflammatory responses [54]. SCFAs promote overall health by facilitating the formation of GCs [55]. Nano-Se substantially increased the concentrations of butyric, acetic, and propionic acid in the feces of mice with DSS-induced colitis. Consequently, SCFAs constitute a focal point in the mechanism through which nano-Se operates.

5. Conclusions

Cd can destroy the integrity of the intestinal epithelial barrier and intestinal homeostasis, reduce the content of probiotics, and increase intestinal inflammation. Nano-Se can maintain the integrity of the intestinal epithelial barrier and ameliorate Cd damage to intestinal health by regulating short-chain fatty acids and microorganisms in the intestine. In this study, nano-Se was used at a laboratory dose; the suitability of this dose in humans requires further research. This study cannot be applied to the treatment human patients with colitis.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nu16091330/s1, Figure S1: species accumulation curve, abundance grade curve, sequence length distribution, and rarefaction curves analysis; Figure S2: Alpha diversity index analysis; Figure S3: PCA analysis and Beta diversity analysis; Figure S4: Analysis of dominant species based on relative abundance phylum level.

Author Contributions

C.Z. and S.G. performed research and drafted the manuscript. P.G. contributed new reagents or analytic tools. W.Y. and Q.B. designed research and provide fund support. All data were generated in-house, and no paper mill was used. All authors agree to be accountable for all aspects of work ensuring integrity and accuracy. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Nature Science Foundation: 81630086, 82030099 and 81973078; The National Key R&D Program of China (2022YFF0606703); The Open Foundation of Shaanxi University of Chinese Medicine Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (KF202330); The Innovative research team of high-level local universities in Shanghai; Shaanxi Provincial Agricultural Science and Technology Innovation Project: NYKJ-2023-(XA)02; Xi’an Science and Technology Plan Project: 22NYYF038; Scientific Research Program Funded by Shaanxi Provincial Education Department (Program No. 23JK0352); Shaanxi Province scientific and technological innovation team: 2023-CX-TD-61.

Institutional Review Board Statement

This study strictly followed the National Research Council’s Guide for the Care and Use of Laboratory Animals.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author/s.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Chakraborty, K.; Chatterjee, S.; Bhattacharyya, A. Modulation of phenotypic and functional maturation of murine bone-marrow-derived dendritic cells (BMDCs) induced by cadmium chloride. Int. Immunopharmacol. 2014, 20, 131–140. [Google Scholar] [CrossRef] [PubMed]
  2. Hossein-Khannazer, N.; Azizi, G.; Eslami, S.; Alhassan Mohammed, H.; Fayyaz, F.; Hosseinzadeh, R.; Usman, A.B.; Kamali, A.N.; Mohammadi, H.; Jadidi-Niaragh, F. The effects of cadmium exposure in the induction of inflammation. Immunopharmacol. Immunotoxicol. 2020, 42, 1–8. [Google Scholar] [CrossRef]
  3. Lener, M.R.; Reszka, E.; Marciniak, W.; Lesicka, M.; Baszuk, P.; Jabłońska, E.; Białkowska, K.; Muszyńska, M.; Pietrzak, S.; Derkacz, R. Blood cadmium levels as a marker for early lung cancer detection. J. Trace Elem. Med. Biol. 2021, 64, 126682. [Google Scholar] [CrossRef] [PubMed]
  4. Satarug, S.; Vesey, D.A.; Gobe, G.C. Current health risk assessment practice for dietary cadmium: Data from different countries. Food Chem. Toxicol. 2017, 106, 430–445. [Google Scholar] [CrossRef]
  5. Ma, Y.; Su, Q.; Yue, C.; Zou, H.; Zhu, J.; Zhao, H.; Song, R.; Liu, Z. The effect of oxidative stress-induced autophagy by cadmium exposure in kidney, liver, and bone damage, and neurotoxicity. Int. J. Mol. Sci. 2022, 23, 13491. [Google Scholar] [CrossRef] [PubMed]
  6. Hartwig, A. Cadmium and cancer. In Cadmium: From Toxicity to Essentiality; Springer: Dordrecht, The Netherlands, 2013; pp. 491–507. [Google Scholar]
  7. McElroy, J.A.; Shafer, M.M.; Trentham-Dietz, A.; Hampton, J.M.; Newcomb, P.A. Cadmium exposure and breast cancer risk. J. Natl. Cancer Inst. 2006, 98, 869–873. [Google Scholar] [CrossRef]
  8. Tinkov, A.A.; Filippini, T.; Ajsuvakova, O.P.; Skalnaya, M.G.; Aaseth, J.; Bjørklund, G.; Gatiatulina, E.R.; Popova, E.V.; Nemereshina, O.N.; Huang, P.-T. Cadmium and atherosclerosis: A review of toxicological mechanisms and a meta-analysis of epidemiologic studies. Environ. Res. 2018, 162, 240–260. [Google Scholar] [CrossRef]
  9. Combs, G.F., Jr.; Lü, J. Selenium as a cancer preventive agent. In Selenium: Its Molecular Biology and Role in Human Health; Springer: Berlin/Heidelberg, Germany, 2001; pp. 249–264. [Google Scholar]
  10. Arruebarrena, M.A.; Hawe, C.T.; Lee, Y.M.; Branco, R.C. Mechanisms of Cadmium Neurotoxicity. Int. J. Mol. Sci. 2023, 24, 16558. [Google Scholar] [CrossRef] [PubMed]
  11. Knoell, D.L.; Wyatt, T.A. The adverse impact of cadmium on immune function and lung host defense. Semin. Cell Dev. Biol. 2021, 115, 70–76. [Google Scholar] [CrossRef]
  12. Wang, Z.; Sun, Y.; Yao, W.; Ba, Q.; Wang, H. Effects of cadmium exposure on the immune system and immunoregulation. Front. Immunol. 2021, 12, 695484. [Google Scholar] [CrossRef]
  13. Adegoke, A.; Salami, A.; Olaleye, S. Cadmium exacerbates acetic acid induced experimental colitis in rats. Eur. Exp. Biol. 2017, 7, 27. [Google Scholar]
  14. Jiang, Z.; Mu, W.; Yang, Y.; Sun, M.; Liu, Y.; Gao, Z.; Li, J.; Gu, P.; Wang, H.; Lu, Y. Cadmium exacerbates dextran sulfate sodium-induced chronic colitis and impairs intestinal barrier. Sci. Total Environ. 2020, 744, 140844. [Google Scholar] [CrossRef]
  15. Toubhans, B.; Gazze, S.A.; Bissardon, C.; Bohic, S.; Gourlan, A.T.; Gonzalez, D.; Charlet, L.; Conlan, R.S.; Francis, L.W. Selenium nanoparticles trigger alterations in ovarian cancer cell biomechanics. Nanomed. Nanotechnol. Biol. Med. 2020, 29, 102258. [Google Scholar] [CrossRef] [PubMed]
  16. Sonkusre, P.; Cameotra, S.S. Biogenic selenium nanoparticles induce ROS-mediated necroptosis in PC-3 cancer cells through TNF activation. J. Nanobiotechnology 2017, 15, 43. [Google Scholar] [CrossRef]
  17. El-Borady, O.M.; Othman, M.S.; Atallah, H.H.; Moneim, A.E.A. Hypoglycemic potential of selenium nanoparticles capped with polyvinyl-pyrrolidone in streptozotocin-induced experimental diabetes in rats. Heliyon 2020, 6, e04045. [Google Scholar] [CrossRef] [PubMed]
  18. Chen, H.; Qiu, Q.; Zou, C.; Dou, L.; Liang, J. Regulation of hepatic carbohydrate metabolism by selenium during diabetes. Chem. -Biol. Interact. 2015, 232, 1–6. [Google Scholar] [CrossRef]
  19. Zhang, X.; Liu, C.; Guo, J.; Song, Y. Selenium status and cardiovascular diseases: Meta-analysis of prospective observational studies and randomized controlled trials. Eur. J. Clin. Nutr. 2016, 70, 162–169. [Google Scholar] [CrossRef]
  20. Gîlcă-Blanariu, G.-E.; Diaconescu, S.; Ciocoiu, M.; Ștefănescu, G. New insights into the role of trace elements in IBD. BioMed Res. Int. 2018, 2018, 1813047. [Google Scholar] [CrossRef]
  21. Short, S.P.; Pilat, J.M.; Williams, C.S. Roles for selenium and selenoprotein P in the development, progression, and prevention of intestinal disease. Free. Radic. Biol. Med. 2018, 127, 26–35. [Google Scholar] [CrossRef]
  22. Kaushal, N.; Kudva, A.K.; Patterson, A.D.; Chiaro, C.; Kennett, M.J.; Desai, D.; Amin, S.; Carlson, B.A.; Cantorna, M.T.; Prabhu, K.S. Crucial role of macrophage selenoproteins in experimental colitis. J. Immunol. 2014, 193, 3683–3692. [Google Scholar] [CrossRef]
  23. Rayman, M.P.; Winther, K.H.; Pastor-Barriuso, R.; Cold, F.; Thvilum, M.; Stranges, S.; Guallar, E.; Cold, S. Effect of long-term selenium supplementation on mortality: Results from a multiple-dose, randomised controlled trial. Free. Radic. Biol. Med. 2018, 127, 46–54. [Google Scholar] [CrossRef] [PubMed]
  24. Baum, M.K.; Campa, A.; Lai, S.; Martinez, S.S.; Tsalaile, L.; Burns, P.; Farahani, M.; Li, Y.; Van Widenfelt, E.; Page, J.B. Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: A randomized clinical trial. Jama 2013, 310, 2154–2163. [Google Scholar] [CrossRef] [PubMed]
  25. Hurwitz, B.E.; Klaus, J.R.; Llabre, M.M.; Gonzalez, A.; Lawrence, P.J.; Maher, K.J.; Greeson, J.M.; Baum, M.K.; Shor-Posner, G.; Skyler, J.S. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: A randomized controlled trial. Arch. Intern. Med. 2007, 167, 148–154. [Google Scholar] [CrossRef] [PubMed]
  26. Kieliszek, M.; Błażejak, S. Current knowledge on the importance of selenium in food for living organisms: A review. Molecules 2016, 21, 609. [Google Scholar] [CrossRef] [PubMed]
  27. Zwolak, I. The role of selenium in arsenic and cadmium toxicity: An updated review of scientific literature. Biol. Trace Elem. Res. 2020, 193, 44–63. [Google Scholar] [CrossRef] [PubMed]
  28. Barceló, J.; Poschenrieder, C. Hyperaccumulation of trace elements: From uptake and tolerance mechanisms to litter decomposition; selenium as an example. Plant Soil 2011, 341, 31–35. [Google Scholar] [CrossRef]
  29. Liu, S.; Yu, H.; Li, P.; Wang, C.; Liu, G.; Zhang, X.; Zhang, C.; Qi, M.; Ji, H. Dietary nano-selenium alleviated intestinal damage of juvenile grass carp (Ctenopharyngodon idella) induced by high-fat diet: Insight from intestinal morphology, tight junction, inflammation, anti-oxidization and intestinal microbiota. Anim. Nutr. 2022, 8, 235–248. [Google Scholar] [CrossRef] [PubMed]
  30. Ye, R.; Guo, Q.; Huang, J.; Wang, Z.; Chen, Y.; Dong, Y. Eucommia ulmoides polysaccharide modified nano-selenium effectively alleviated DSS-induced colitis through enhancing intestinal mucosal barrier function and antioxidant capacity. J. Nanobiotechnology 2023, 21, 222. [Google Scholar] [CrossRef] [PubMed]
  31. Tarmizi, A.A.A.; Adam, S.H.; Ramli, N.N.N.; Abd, N.A. The Ameliorative Effects of Selenium Nanoparticles (SeNPs) on Diabetic Rat Model: A Narrative Review. Sains Malays. 2023, 52, 2037–2053. [Google Scholar] [CrossRef]
  32. BenithaJ, G.; Gheena, S.; Ramani, P.; Kumar, R.; Ramalingam, K.; Ramasubramaniam, A. Anticancer activity of green synthesized selenium nanoparticles from garcinia mangostana crude extract against MCF-7 breast cancer cells. J. Popul. Ther. Clin. Pharmacol. 2023, 30, 74–82. [Google Scholar]
  33. Martínez-Esquivias, F.; Perez-Larios, A.; Guzmán-Flores, J.M. Effect of Administration of Selenium Nanoparticles Synthesized Using Onion Extract on Biochemical and Inflammatory Parameters in Mice Fed with High-Fructose Diet: In Vivo and In Silico Analysis. Biol. Trace Elem. Res. 2024, 202, 558–568. [Google Scholar] [CrossRef] [PubMed]
  34. Ge, J.; Guo, K.; Zhang, C.; Talukder, M.; Lv, M.-W.; Li, J.-Y.; Li, J.-L. Comparison of nanoparticle-selenium, selenium-enriched yeast and sodium selenite on the alleviation of cadmium-induced inflammation via NF-kB/IκB pathway in heart. Sci. Total Environ. 2021, 773, 145442. [Google Scholar] [CrossRef] [PubMed]
  35. Sang, L.-X.; Chang, B.; Zhu, J.-F.; Yang, F.-L.; Li, Y.; Jiang, X.-F.; Wang, D.-N.; Lu, C.-L.; Sun, X. Sodium selenite ameliorates dextran sulfate sodium-induced chronic colitis in mice by decreasing Th1, Th17, and γδT and increasing CD4 (+) CD25 (+) regulatory T-cell responses. World J. Gastroenterol. 2017, 23, 3850. [Google Scholar] [CrossRef] [PubMed]
  36. Bär, F.; Bochmann, W.; Widok, A.; Von Medem, K.; Pagel, R.; Hirose, M.; Yu, X.; Kalies, K.; König, P.; Böhm, R. Mitochondrial gene polymorphisms that protect mice from colitis. Gastroenterology 2013, 145, 1055–1063.e1053. [Google Scholar] [CrossRef] [PubMed]
  37. Chen, X.; Liu, X.-S. Hydrogen sulfide from a NaHS source attenuates dextran sulfate sodium (DSS)-induced inflammation via inhibiting nuclear factor-κB. J. Zhejiang Univ. Sci. B 2016, 17, 209. [Google Scholar] [CrossRef] [PubMed]
  38. Wang, H.; Huang, X.; Xia, S.; Chen, C.; Chen, X.; Zhang, Y.; Farag, M.A.; Xiao, J.; Nie, S. Celery soluble dietary fiber antagonizes flavonoids ameliorative effect on dextran-sodium-sulfate-induced colitis in mice. J. Adv. Res. 2023, 52, 73–88. [Google Scholar] [CrossRef] [PubMed]
  39. Liu, J.; Teng, P.-Y.; Kim, W.K.; Applegate, T.J. Assay considerations for fluorescein isothiocyanate-dextran (FITC-d): An indicator of intestinal permeability in broiler chickens. Poult. Sci. 2021, 100, 101202. [Google Scholar] [CrossRef]
  40. Kim, K.-S.; Lee, Y.; Chae, W.; Cho, J.-Y. An Improved Method to Quantify Short-Chain Fatty Acids in Biological Samples Using Gas Chromatography—Mass Spectrometry. Metabolites 2022, 12, 525. [Google Scholar] [CrossRef] [PubMed]
  41. Canfora, E.E.; Jocken, J.W.; Blaak, E.E. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat. Rev. Endocrinol. 2015, 11, 577–591. [Google Scholar] [CrossRef]
  42. Wang, P.; Chen, H.; Kopittke, P.M.; Zhao, F.-J. Cadmium contamination in agricultural soils of China and the impact on food safety. Environ. Pollut. 2019, 249, 1038–1048. [Google Scholar] [CrossRef]
  43. Guo, K.; Ge, J.; Zhang, C.; Lv, M.-W.; Zhang, Q.; Talukder, M.; Li, J.-L. Cadmium induced cardiac inflammation in chicken (Gallus gallus) via modulating cytochrome P450 systems and Nrf2 mediated antioxidant defense. Chemosphere 2020, 249, 125858. [Google Scholar] [CrossRef] [PubMed]
  44. Newairy, A.; El-Sharaky, A.; Badreldeen, M.; Eweda, S.; Sheweita, S. The hepatoprotective effects of selenium against cadmium toxicity in rats. Toxicology 2007, 242, 23–30. [Google Scholar] [CrossRef]
  45. Hiller, F.; Oldorff, L.; Besselt, K.; Kipp, A.P. Differential acute effects of selenomethionine and sodium selenite on the severity of colitis. Nutrients 2015, 7, 2687–2706. [Google Scholar] [CrossRef] [PubMed]
  46. Brown, S.J.; Mayer, L. The Immune Response in Inflammatory Bowel Disease. Off. J. Am. Coll. Gastroenterol. Assoc. Can. De Gastroenterol. 2007, 102, 2058–2069. [Google Scholar] [CrossRef] [PubMed]
  47. Luo, S.; Terciolo, C.; Bracarense, A.P.F.; Payros, D.; Pinton, P.; Oswald, I.P. In vitro and in vivo effects of a mycotoxin, deoxynivalenol, and a trace metal, cadmium, alone or in a mixture on the intestinal barrier. Environ. Int. 2019, 132, 105082. [Google Scholar] [CrossRef] [PubMed]
  48. Shigetomi, K.; Ikenouchi, J. Regulation of the epithelial barrier by post-translational modifications of tight junction membrane proteins. J. Biochem. 2018, 163, 265–272. [Google Scholar] [CrossRef] [PubMed]
  49. Harris, T.J.; Tepass, U. Adherens junctions: From molecules to morphogenesis. Nat. Rev. Mol. Cell Biol. 2010, 11, 502–514. [Google Scholar] [CrossRef]
  50. Liu, Y.; Li, Y.; Liu, K.; Shen, J. Exposing to cadmium stress cause profound toxic effect on microbiota of the mice intestinal tract. PLoS ONE 2014, 9, e85323. [Google Scholar] [CrossRef]
  51. Kim, E.; Xu, X.; Steiner, H.; Ahmer, B.; Cormet-Boyaka, E.; Boyaka, P. Chronic ingestion of low doses of cadmium alters the gut microbiome and immune homeostasis to enhance allergic sensitization (MUC9P. 743). J. Immunol. 2015, 194, 205–207. [Google Scholar] [CrossRef]
  52. Zhang, Z.; Wu, X.; Cao, S.; Wang, L.; Wang, D.; Yang, H.; Feng, Y.; Wang, S.; Li, L. Caffeic acid ameliorates colitis in association with increased Akkermansia population in the gut microbiota of mice. Oncotarget 2016, 7, 31790. [Google Scholar] [CrossRef]
  53. Xu, R.; Zhang, Y.; Chen, S.; Zeng, Y.; Fu, X.; Chen, T.; Luo, S.; Zhang, X. The role of the probiotic Akkermansia muciniphila in brain functions: Insights underpinning therapeutic potential. Crit. Rev. Microbiol. 2023, 49, 151–176. [Google Scholar] [CrossRef] [PubMed]
  54. Donohoe, D.R.; Garge, N.; Zhang, X.; Sun, W.; O’Connell, T.M.; Bunger, M.K.; Bultman, S.J. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011, 13, 517–526. [Google Scholar] [CrossRef] [PubMed]
  55. Yue, X.; Wen, S.; Long-Kun, D.; Man, Y.; Chang, S.; Min, Z.; Shuang-Yu, L.; Xin, Q.; Jie, M.; Liang, W. Three important short-chain fatty acids (SCFAs) attenuate the inflammatory response induced by 5-FU and maintain the integrity of intestinal mucosal tight junction. BMC Immunol. 2022, 23, 19. [Google Scholar] [CrossRef] [PubMed]
Nutrients 16 01330 g001
Figure 1. Effect of DSS-induced chronic colitis in mice. (A) The modeling scheme of DSS-induced chronic colitis with nano-selenium: Mice were randomly divided into control group (Ctrl), DSS group (DSS), DSS + Cd, DSS + Cd+ nano-selenium (0.5 mg/kg) group (DCS (0.5 mg/kg)), DSS + Cd+ nano-selenium (1 mg/kg) group (DCS (1 mg/kg)). Mice in the control group only received normal drinking water, while mice in the treatment groups received DSS (2% w/v) dissolved in drinking water. For nano-selenium (0.5 mg/Kg) and nano-selenium (1 mg/kg) groups, nano-selenium was administered by gavage after DSS exposure. Each cycle includes 1 week of DSS administration followed by 2 weeks of recovery with normal drinking water. The relative body weight curve (C) and disease activity index (DAI) score (D) of mice were recorded. After the modeling (end of week 7), mice were sacrificed to collect tissue and measure the length of the colon (B), the weight/length ratio of the colon (E), and spleen weight (F) of mice were calculated. The data are presented as means ± SEM. ns ≥ 0.05, * p < 0.05, ** p < 0.01, **** p < 0.0001.
Figure 1. Effect of DSS-induced chronic colitis in mice. (A) The modeling scheme of DSS-induced chronic colitis with nano-selenium: Mice were randomly divided into control group (Ctrl), DSS group (DSS), DSS + Cd, DSS + Cd+ nano-selenium (0.5 mg/kg) group (DCS (0.5 mg/kg)), DSS + Cd+ nano-selenium (1 mg/kg) group (DCS (1 mg/kg)). Mice in the control group only received normal drinking water, while mice in the treatment groups received DSS (2% w/v) dissolved in drinking water. For nano-selenium (0.5 mg/Kg) and nano-selenium (1 mg/kg) groups, nano-selenium was administered by gavage after DSS exposure. Each cycle includes 1 week of DSS administration followed by 2 weeks of recovery with normal drinking water. The relative body weight curve (C) and disease activity index (DAI) score (D) of mice were recorded. After the modeling (end of week 7), mice were sacrificed to collect tissue and measure the length of the colon (B), the weight/length ratio of the colon (E), and spleen weight (F) of mice were calculated. The data are presented as means ± SEM. ns ≥ 0.05, * p < 0.05, ** p < 0.01, **** p < 0.0001.
Nutrients 16 01330 g001
Nutrients 16 01330 g002
Figure 2. Nano-selenium treatment reduced colonic inflammatory cytokines expression. Relative mRNA levels of IL-1β, IL-6, MCP1, TNF-α, and IFN-γ in the colon were measured through qPCR (n = 8–12). The data are presented as means ± SEM. ns ≥ 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Figure 2. Nano-selenium treatment reduced colonic inflammatory cytokines expression. Relative mRNA levels of IL-1β, IL-6, MCP1, TNF-α, and IFN-γ in the colon were measured through qPCR (n = 8–12). The data are presented as means ± SEM. ns ≥ 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Nutrients 16 01330 g002
Nutrients 16 01330 g003
Figure 3. Nano-selenium treatment protects the intestinal barrier in mice. Microscopic appearance by using H&E staining of the colon tissues. The inflammatory cell infiltration is indicated with (asterisk). The crypt damage is indicated with (arrow). The data are presented as means ± SEM. ns ≥ 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Figure 3. Nano-selenium treatment protects the intestinal barrier in mice. Microscopic appearance by using H&E staining of the colon tissues. The inflammatory cell infiltration is indicated with (asterisk). The crypt damage is indicated with (arrow). The data are presented as means ± SEM. ns ≥ 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Nutrients 16 01330 g003
Nutrients 16 01330 g004
Figure 4. The PAS stain of goblet cells in the colon. Quantification of goblet cell depletion in the colon (n = 6). The data are presented as means ± SEM. ns ≥ 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 4. The PAS stain of goblet cells in the colon. Quantification of goblet cell depletion in the colon (n = 6). The data are presented as means ± SEM. ns ≥ 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001.
Nutrients 16 01330 g004
Nutrients 16 01330 g005
Figure 5. Serum FITC content. The data are presented as means ± SEM (n = 3). The data are presented as means ± SEM. ns ≥ 0.05, ** p < 0.01, *** p < 0.001.
Figure 5. Serum FITC content. The data are presented as means ± SEM (n = 3). The data are presented as means ± SEM. ns ≥ 0.05, ** p < 0.01, *** p < 0.001.
Nutrients 16 01330 g005
Nutrients 16 01330 g006
Figure 6. Effect of nano-Se on plasma inflammatory cytokines. The relative levels of IL-1β, IL-6, MCP1, and IFN-γ in plasma were measured by using ELISA. The data are presented as means ± SEM (n = 3). The data are presented as means ± SEM. ns ≥ 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 6. Effect of nano-Se on plasma inflammatory cytokines. The relative levels of IL-1β, IL-6, MCP1, and IFN-γ in plasma were measured by using ELISA. The data are presented as means ± SEM (n = 3). The data are presented as means ± SEM. ns ≥ 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001.
Nutrients 16 01330 g006
Nutrients 16 01330 g007
Figure 7. Nano-Se affects the content of SCFAs in feces. The data are presented as means ± SEM. ns ≥ 0.05, * p < 0.05, *** p < 0.001, **** p < 0.0001.
Figure 7. Nano-Se affects the content of SCFAs in feces. The data are presented as means ± SEM. ns ≥ 0.05, * p < 0.05, *** p < 0.001, **** p < 0.0001.
Nutrients 16 01330 g007
Nutrients 16 01330 g008
Figure 8. Notes on species taxonomy and analysis of ASV Venn diagram. (A) Notes on species taxonomy; (B) ASV Venn diagram.
Figure 8. Notes on species taxonomy and analysis of ASV Venn diagram. (A) Notes on species taxonomy; (B) ASV Venn diagram.
Nutrients 16 01330 g008
Nutrients 16 01330 g009
Figure 9. Analysis of species difference at the phylum level of nano-selenium intervention in DSS-induced enteritis. The data are presented as means ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 9. Analysis of species difference at the phylum level of nano-selenium intervention in DSS-induced enteritis. The data are presented as means ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.
Nutrients 16 01330 g009
Nutrients 16 01330 g010
Figure 10. Analysis of dominant species based on relative abundance family level. (A) relative abundance information of species at genus level; (B) classification-level tree diagram; (C) hierarchical cluster analysis; (D) species composition heatmap.
Figure 10. Analysis of dominant species based on relative abundance family level. (A) relative abundance information of species at genus level; (B) classification-level tree diagram; (C) hierarchical cluster analysis; (D) species composition heatmap.
Nutrients 16 01330 g010
Nutrients 16 01330 g011
Figure 11. Analysis of species difference at the genus level of nano-selenium in intervention of DSS-induced enteritis. The data are presented as means ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 11. Analysis of species difference at the genus level of nano-selenium in intervention of DSS-induced enteritis. The data are presented as means ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.
Nutrients 16 01330 g011
Nutrients 16 01330 g012
Figure 12. Correlation analysis between the relative abundance of species and related indexes of enteritis. (A) LefSe analysis; (B) genus-level evolutionary tree; (C) correlation analysis between the relative abundance of species and enteritis-related indicators. The data are presented as means ± SEM. * p < 0.05, ** p < 0.01.
Figure 12. Correlation analysis between the relative abundance of species and related indexes of enteritis. (A) LefSe analysis; (B) genus-level evolutionary tree; (C) correlation analysis between the relative abundance of species and enteritis-related indicators. The data are presented as means ± SEM. * p < 0.05, ** p < 0.01.
Nutrients 16 01330 g012
Table 1. DAI scoring system.
Table 1. DAI scoring system.
ScoreBody Weight LossFecal ConsistencyFecal Occult Blood
00NegativeNegative
11–5%Soft stoolLight blue
25–10%Mucoid stoolBlue
310–20%Watery stoolDark blue
4>20% Gross blood
Table 2. Histological scoring system.
Table 2. Histological scoring system.
ScoreSeverity of InflammationDepth of InjuryCrypt DamagePercentage of the Involved Area
0NoneNoneNone
1SlightMucosalBasal 1/3 damaged1–10%
2ModerateMucosal and
submucosal		Basal 2/3 damaged10–25%
3SevereTransmural Only surface
epithelium intact		25–50%
4 Entire crypt and
epithelium lost		50–100%
Table 3. Primers for real-time PCR analysis.
Table 3. Primers for real-time PCR analysis.
GeneSenseAnti-Sense
IL-1βGCAACTGTTCCTGAACTCAACTATCTTTTGGGGTCCGTCAACT
TNF-αGCCTCCTCACCCACCACCATCACCAAGTAGACCTGCCCAGACT
IL-6GAGGATACCACTCCCAACAGACCAAGTGCATCATCGTTGTTCATACA
MCP1TTAAAAACCTGGATCGGAACCAAGCATTAGCTTCAGATTTACGGGT
IFN-γATGAACGCTACACACTGCATCCCATCCTTTTGCCAGTTCCTC
β-actinGGCTGTATTCCCCTCCATCGCCAGTTGGTAACAATGCCATGT
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhou, C.; Guo, S.; Gong, P.; Ba, Q.; Yao, W. Nano-Selenium Alleviates Cd-Induced Chronic Colitis through Intestinal Flora. Nutrients 2024, 16, 1330. https://doi.org/10.3390/nu16091330

AMA Style

Zhou C, Guo S, Gong P, Ba Q, Yao W. Nano-Selenium Alleviates Cd-Induced Chronic Colitis through Intestinal Flora. Nutrients. 2024; 16(9):1330. https://doi.org/10.3390/nu16091330

Chicago/Turabian Style

Zhou, Chengdong, Shengliang Guo, Pin Gong, Qian Ba, and Wenbo Yao. 2024. "Nano-Selenium Alleviates Cd-Induced Chronic Colitis through Intestinal Flora" Nutrients 16, no. 9: 1330. https://doi.org/10.3390/nu16091330

APA Style

Zhou, C., Guo, S., Gong, P., Ba, Q., & Yao, W. (2024). Nano-Selenium Alleviates Cd-Induced Chronic Colitis through Intestinal Flora. Nutrients, 16(9), 1330. https://doi.org/10.3390/nu16091330

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop